« Back to Record
Awada, A., Bachelot, T., Goswami, C., Deo, S., Bose, R., Wong, A., Xu, F., Yao, B., Bryce, R., Carey, L. L., Colomer, R., Inoue, K., Bondarenko, I. I., Badwe, R., Demetriou, G., Lee, S. C., Mehta, A. A., & Kim, S.-B. (2016). Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial. JAMA oncology, 2(12), 1557-1564. doi:10.1001/jamaoncol.2016.0237
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247836



